United Therapeutics Chairperson, CEO Martine Rothblatt reports disposal of 9,500 common shares worth $5.04 million - UTHR News | RalliesUnited Therapeutics Chairperson, CEO Martine Rothblatt reports disposal of 9,500 common shares worth $5.04 million
U
UTHR• Insider filing details option exercise and share sales
- United Therapeutics Chairperson and CEO Martine A. Rothblatt reported an option exercise for 9,500 shares at USD 135.42 on July 21, 2026.
- The filing also shows sales totaling 9,500 shares on the same day at weighted-average prices ranging from USD 524.37 to USD 536.37.
- Holdings in the reporting trust were 324,443 shares following the transactions.
